Selected research
Industry Growth & Trends
Global Azithromycin Drug Industry Growth and Trends Forecast to 2032
Market perspective
The global Azithromycin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Azithromycin Drug include Teva, Sandoz, Mylan, Pfizer, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Zydus Pharmaceuticals, Wockhardt and PLIVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Azithromycin Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Azithromycin Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Azithromycin Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Azithromycin Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Azithromycin Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Azithromycin Drug Market by Company
Teva
Sandoz
Mylan
Pfizer
Hainan Poly Pharm
Hainan Hailing Chemipharma Corporation
Zydus Pharmaceuticals
Wockhardt
PLIVA
Lupin
Gland Pharma Limited
CSPC Ouyi Pharmaceutical
CSPC
Aurobindo Pharma
Akorn
Azithromycin Drug Segment by Type
Oral
Injection
Azithromycin Drug Segment by Application
Hospital
Drug Store
Azithromycin Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azithromycin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Azithromycin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Azithromycin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Sandoz
- Mylan
- Pfizer
- Hainan Poly Pharm
- Hainan Hailing Chemipharma Corporation
- Zydus Pharmaceuticals
- Wockhardt
- PLIVA
- Lupin
- Gland Pharma Limited
- CSPC Ouyi Pharmaceutical
- CSPC
- Aurobindo Pharma
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Azithromycin Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Azithromycin Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Azithromycin Drug Market by Type
- 1.3.1 Oral
- 1.3.2 Injection
- 1.4 Global Azithromycin Drug Market Size by Type
- 1.4.1 Global Azithromycin Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Azithromycin Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Azithromycin Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Azithromycin Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Azithromycin Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Azithromycin Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Azithromycin Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Azithromycin Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Azithromycin Drug Industry Trends
- 2.2 Azithromycin Drug Industry Drivers
- 2.3 Azithromycin Drug Industry Opportunities and Challenges
- 2.4 Azithromycin Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Azithromycin Drug Revenue (2021-2026)
- 3.2 Global Top Players by Azithromycin Drug Sales (2021-2026)
- 3.3 Global Top Players by Azithromycin Drug Price (2021-2026)
- 3.4 Global Azithromycin Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Azithromycin Drug Major Company Production Sites & Headquarters
- 3.6 Global Azithromycin Drug Company, Product Type & Application
- 3.7 Global Azithromycin Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Azithromycin Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Azithromycin Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Azithromycin Drug Tier 1, Tier 2, and Tier 3
4 Azithromycin Drug Regional Status and Outlook
- 4.1 Global Azithromycin Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Azithromycin Drug Historic Market Size by Region
- 4.2.1 Global Azithromycin Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Azithromycin Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Azithromycin Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Azithromycin Drug Forecasted Market Size by Region
- 4.3.1 Global Azithromycin Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Azithromycin Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Azithromycin Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Azithromycin Drug by Application
- 5.1 Azithromycin Drug Market by Application
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.2 Global Azithromycin Drug Market Size by Application
- 5.2.1 Global Azithromycin Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Azithromycin Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Azithromycin Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Azithromycin Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Azithromycin Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Azithromycin Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Azithromycin Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Azithromycin Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Azithromycin Drug Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sandoz
- 6.2.1 Sandoz Company Information
- 6.2.2 Sandoz Business Overview
- 6.2.3 Sandoz Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sandoz Azithromycin Drug Product Portfolio
- 6.2.5 Sandoz Recent Developments
- 6.3 Mylan
- 6.3.1 Mylan Company Information
- 6.3.2 Mylan Business Overview
- 6.3.3 Mylan Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mylan Azithromycin Drug Product Portfolio
- 6.3.5 Mylan Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Azithromycin Drug Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Hainan Poly Pharm
- 6.5.1 Hainan Poly Pharm Company Information
- 6.5.2 Hainan Poly Pharm Business Overview
- 6.5.3 Hainan Poly Pharm Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hainan Poly Pharm Azithromycin Drug Product Portfolio
- 6.5.5 Hainan Poly Pharm Recent Developments
- 6.6 Hainan Hailing Chemipharma Corporation
- 6.6.1 Hainan Hailing Chemipharma Corporation Company Information
- 6.6.2 Hainan Hailing Chemipharma Corporation Business Overview
- 6.6.3 Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio
- 6.6.5 Hainan Hailing Chemipharma Corporation Recent Developments
- 6.7 Zydus Pharmaceuticals
- 6.7.1 Zydus Pharmaceuticals Company Information
- 6.7.2 Zydus Pharmaceuticals Business Overview
- 6.7.3 Zydus Pharmaceuticals Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Zydus Pharmaceuticals Azithromycin Drug Product Portfolio
- 6.7.5 Zydus Pharmaceuticals Recent Developments
- 6.8 Wockhardt
- 6.8.1 Wockhardt Company Information
- 6.8.2 Wockhardt Business Overview
- 6.8.3 Wockhardt Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Wockhardt Azithromycin Drug Product Portfolio
- 6.8.5 Wockhardt Recent Developments
- 6.9 PLIVA
- 6.9.1 PLIVA Company Information
- 6.9.2 PLIVA Business Overview
- 6.9.3 PLIVA Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 PLIVA Azithromycin Drug Product Portfolio
- 6.9.5 PLIVA Recent Developments
- 6.10 Lupin
- 6.10.1 Lupin Company Information
- 6.10.2 Lupin Business Overview
- 6.10.3 Lupin Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Lupin Azithromycin Drug Product Portfolio
- 6.10.5 Lupin Recent Developments
- 6.11 Gland Pharma Limited
- 6.11.1 Gland Pharma Limited Company Information
- 6.11.2 Gland Pharma Limited Business Overview
- 6.11.3 Gland Pharma Limited Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Gland Pharma Limited Azithromycin Drug Product Portfolio
- 6.11.5 Gland Pharma Limited Recent Developments
- 6.12 CSPC Ouyi Pharmaceutical
- 6.12.1 CSPC Ouyi Pharmaceutical Company Information
- 6.12.2 CSPC Ouyi Pharmaceutical Business Overview
- 6.12.3 CSPC Ouyi Pharmaceutical Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio
- 6.12.5 CSPC Ouyi Pharmaceutical Recent Developments
- 6.13 CSPC
- 6.13.1 CSPC Company Information
- 6.13.2 CSPC Business Overview
- 6.13.3 CSPC Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 CSPC Azithromycin Drug Product Portfolio
- 6.13.5 CSPC Recent Developments
- 6.14 Aurobindo Pharma
- 6.14.1 Aurobindo Pharma Company Information
- 6.14.2 Aurobindo Pharma Business Overview
- 6.14.3 Aurobindo Pharma Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Aurobindo Pharma Azithromycin Drug Product Portfolio
- 6.14.5 Aurobindo Pharma Recent Developments
- 6.15 Akorn
- 6.15.1 Akorn Company Information
- 6.15.2 Akorn Business Overview
- 6.15.3 Akorn Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Akorn Azithromycin Drug Product Portfolio
- 6.15.5 Akorn Recent Developments
7 North America by Country
- 7.1 North America Azithromycin Drug Sales by Country
- 7.1.1 North America Azithromycin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Azithromycin Drug Sales by Country (2021-2026)
- 7.1.3 North America Azithromycin Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Azithromycin Drug Market Size by Country
- 7.2.1 North America Azithromycin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Azithromycin Drug Market Size by Country (2021-2026)
- 7.2.3 North America Azithromycin Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Azithromycin Drug Sales by Country
- 8.1.1 Europe Azithromycin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Azithromycin Drug Sales by Country (2021-2026)
- 8.1.3 Europe Azithromycin Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Azithromycin Drug Market Size by Country
- 8.2.1 Europe Azithromycin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Azithromycin Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Azithromycin Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Azithromycin Drug Sales by Country
- 9.1.1 Asia-Pacific Azithromycin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Azithromycin Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Azithromycin Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Azithromycin Drug Market Size by Country
- 9.2.1 Asia-Pacific Azithromycin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Azithromycin Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Azithromycin Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Azithromycin Drug Sales by Country
- 10.1.1 South America Azithromycin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Azithromycin Drug Sales by Country (2021-2026)
- 10.1.3 South America Azithromycin Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Azithromycin Drug Market Size by Country
- 10.2.1 South America Azithromycin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Azithromycin Drug Market Size by Country (2021-2026)
- 10.2.3 South America Azithromycin Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Azithromycin Drug Sales by Country
- 11.1.1 Middle East and Africa Azithromycin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Azithromycin Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Azithromycin Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Azithromycin Drug Market Size by Country
- 11.2.1 Middle East and Africa Azithromycin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Azithromycin Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Azithromycin Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Azithromycin Drug Value Chain Analysis
- 12.1.1 Azithromycin Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Azithromycin Drug Production Mode & Process
- 12.2 Azithromycin Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Azithromycin Drug Distributors
- 12.2.3 Azithromycin Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst